These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Comparison of the efficiency of Na+/Ca2+ exchanger or Na+/H+ exchanger inhibition and their combination in reducing coronary reperfusion-induced arrhythmias. Szepesi J; Acsai K; Sebok Z; Prorok J; Pollesello P; Levijoki J; Papp JG; Varro A; Toth A J Physiol Pharmacol; 2015 Apr; 66(2):215-26. PubMed ID: 25903952 [TBL] [Abstract][Full Text] [Related]
63. The role of the myocardial sodium-hydrogen exchanger in mediating ischemic and reperfusion injury. From amiloride to cariporide. Karmazyn M Ann N Y Acad Sci; 1999 Jun; 874():326-34. PubMed ID: 10415544 [TBL] [Abstract][Full Text] [Related]
64. 3-Substituted-(5-arylfuran-2-ylcarbonyl)guanidines as NHE-1 inhibitors. Lee S; Kim T; Lee BH; Yoo SE; Lee K; Yi KY Bioorg Med Chem Lett; 2007 Mar; 17(5):1291-5. PubMed ID: 17189690 [TBL] [Abstract][Full Text] [Related]
72. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia. Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502 [TBL] [Abstract][Full Text] [Related]
73. Na+/H+ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Shipolini AR; Yokoyama H; Galiñanes M; Edmondson SJ; Hearse DJ; Avkiran M Circulation; 1997 Nov; 96(10):3617-25. PubMed ID: 9396463 [TBL] [Abstract][Full Text] [Related]
74. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357 [TBL] [Abstract][Full Text] [Related]
75. Effect of the Na+/H+ antiport inhibitor Hoe 694 on the angiotensin II-induced vascular smooth muscle cell growth. Sachinidis A; Seul C; Ko Y; Düsing R; Vetter H Br J Pharmacol; 1996 Nov; 119(5):787-96. PubMed ID: 8922722 [TBL] [Abstract][Full Text] [Related]
76. Inhibition of Na Kingma JG J Cardiovasc Pharmacol Ther; 2018 May; 23(3):254-269. PubMed ID: 29562750 [TBL] [Abstract][Full Text] [Related]
77. Na(+)/H(+) exchanger in the regulation of platelet activation and paradoxical effects of cariporide. Chang HB; Gao X; Nepomuceno R; Hu S; Sun D Exp Neurol; 2015 Oct; 272():11-6. PubMed ID: 25595121 [TBL] [Abstract][Full Text] [Related]
78. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries. Takahashi K; Takahashi T; Suzuki T; Onishi M; Tanaka Y; Hamano-Takahashi A; Ota T; Kameo K; Matsuda T; Baba A Eur J Pharmacol; 2003 Jan; 458(1-2):155-62. PubMed ID: 12498920 [TBL] [Abstract][Full Text] [Related]
79. A Na+-H+ exchange inhibitor (SM-20550) protects from microvascular deterioration and myocardial injury after reperfusion. Ito Y; Imai S; Ui G; Nakano M; Imai K; Kamiyama H; Naganuma F; Matsui K; Ohashi N; Nagai R Eur J Pharmacol; 1999 Jun; 374(3):355-66. PubMed ID: 10422780 [TBL] [Abstract][Full Text] [Related]
80. Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Strömer H; de Groot MC; Horn M; Faul C; Leupold A; Morgan JP; Scholz W; Neubauer S Circulation; 2000 Jun; 101(23):2749-55. PubMed ID: 10851214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]